LEVETIRACETAM DEXCEL 500

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Składnik aktywny:

LEVETIRACETAM

Dostępny od:

DEXCEL PHARMA TECHNOLOGIES LTD

Kod ATC:

N03AX14

Forma farmaceutyczna:

TABLETS

Skład:

LEVETIRACETAM 500 MG

Droga podania:

PER OS

Typ recepty:

Required

Wyprodukowano przez:

DEXCEL LTD, ISRAEL

Grupa terapeutyczna:

LEVETIRACETAM

Dziedzina terapeutyczna:

LEVETIRACETAM

Wskazania:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Data autoryzacji:

2018-03-31